|
gptkbp:instanceOf
|
Hallucinogen
|
|
gptkbp:ATCCode
|
none
|
|
gptkbp:CASNumber
|
66142-81-2
|
|
gptkbp:category
|
amphetamine
psychedelic
entactogen
|
|
gptkbp:chemicalFormula
|
C10H14BrNO2
|
|
gptkbp:discoveredBy
|
gptkb:Alexander_Shulgin
|
|
gptkbp:effect
|
euphoria
hallucinations
altered perception
empathogenic effects
|
|
gptkbp:excretion
|
renal
|
|
gptkbp:firstSynthesized
|
1974
|
|
gptkbp:halfLife
|
1.5–3.5 hours
|
|
gptkbp:hasSMILES
|
CC(CC1=CC(=C(C=C1OC)Br)OC)N
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
2CB
|
|
gptkbp:includes
|
gptkb:PiHKAL
|
|
gptkbp:IUPACName
|
4-bromo-2,5-dimethoxyphenethylamine
|
|
gptkbp:legalStatus
|
gptkb:Schedule_III_(Canada)
gptkb:Schedule_I_(United_States)
gptkb:Class_A_(United_Kingdom)
|
|
gptkbp:metabolism
|
hepatic
|
|
gptkbp:molecularWeight
|
260.13 g/mol
|
|
gptkbp:potential_risks
|
gptkb:hallucinogen_persisting_perception_disorder
nausea
anxiety
overstimulation
|
|
gptkbp:PubChem_CID
|
170863
197005
CHEMBL1081962
|
|
gptkbp:relatedTo
|
gptkb:MDMA
gptkb:2C-E
gptkb:2C-I
DOB
2C-B-FLY
|
|
gptkbp:routeOfAdministration
|
oral
insufflation
rectal
|
|
gptkbp:schedule_in_Germany
|
Anlage I
|
|
gptkbp:street_names
|
gptkb:Venus
gptkb:Nexus
Bromo
|
|
gptkbp:UNII
|
U4F3785M35
|
|
gptkbp:used_recreationally
|
yes
|
|
gptkbp:bfsParent
|
gptkb:Grauer_Beton
|
|
gptkbp:bfsLayer
|
8
|